Lomitapide Impurity Detection via HPLC and MS
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Lomitapide compositions often contain process impurities such as unreacted starting materials, chemical derivatives, and degradation products, which affect purity and stability, necessitating effective methods for identifying and quantifying these impurities to meet pharmaceutical standards.
Innovation Solution
A lomitapide composition with less than 0.1% by weight of a carbamate impurity, along with methods using HPLC, MS, NMR, and other spectral analyses to determine the presence and amount of impurities, ensuring compliance with purity standards.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If lomitapide is manufactured through chemical synthesis and storage, then the product is produced and made available, but process impurities and degradation products are formed, reducing purity
Solution Approach 1:
The patent applies preliminary action by establishing controlled manufacturing conditions and storage parameters before impurity formation occurs. The method prevents impurity generation by optimizing reaction conditions, controlling storage temperature and humidity, and implementing preventive measures during the manufacturing process rather than addressing impurities after they form.
Solution Approach 2:
The patent utilizes parameter changes by systematically varying and optimizing critical process parameters such as temperature, humidity, reaction time, and storage conditions. By controlling these parameters within specific ranges, the method minimizes degradation reactions and impurity formation while maintaining productive manufacturing and storage processes.
2Measurement precision
If analytical methods are used to detect impurities at low concentrations, then impurity detection capability is improved, but the complexity and cost of analysis increases
Solution Approach 1:
The patent applies segmentation by dividing the analytical process into multiple stages with different detection methods. Initial screening uses simpler, less expensive methods to identify potential impurities, followed by more sophisticated analytical techniques only when needed for confirmation and quantification. This segmented approach maintains high detection sensitivity while reducing overall analytical complexity and cost.
Solution Approach 2:
The patent employs intermediary substances or reagents that enhance the detectability of impurities through specific chemical reactions or interactions. These intermediaries amplify the signal from trace impurities, enabling detection at low concentrations using relatively simple analytical equipment, thereby reducing the need for complex instrumentation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The described composition and analysis methods ensure the presence of impurities is minimized, maintaining the stability and purity of lomitapide, aligning with regulatory guidelines for pharmaceutical use.
Implementation Method 1
high performance liquid chromatography (HPLC)
Implementation Method 2
mass spectrometry (MS)
Implementation Method 3
nuclear magnetic resonance (NMR) spectroscopy
Data Source
AI summary
The present disclosure relates to compositions comprising impurities (e.g., carbamate and/or hydrolysis products) in a lomitapide sample and methods of detecting such impurities.